title: Beyond insulin: what else might help?
authors.forename: Gary
authors.initials: G
authors.lastname: Scheiner
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018819:Dipeptidyl Peptidase 4; D052216:Glucagon-Like Peptide 1 / Q000819:agonists; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D058228:Islet Amyloid Polypeptide / Q000008:administration & dosage / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D045162:Thiazolidinediones / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D011480:Protease Inhibitors; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D045162:Thiazolidinediones; D052216:Glucagon-Like Peptide 1; D008687:Metformin; C105254:pramlintide; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4